While elevated FABP4 has been well demonstrated in obesity, the metabolic syndrome, and type 2 diabetes and likely contributes to the well-documented insulin resistance in these pathological conditions, to the best of our knowledge this is the first report demonstrating an important physiological role of this adipokine. This evidence concerns the gene FABP4 and type 2 diabetes mellitus.